- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Sun Pharma Advanced Research Company incorporates wholly owned subsidiary Genokine Biotech

Mumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced the incorporation of its wholly owned subsidiary, Genokine Biotech Limited. The new entity was officially incorporated on July 4, 2025, with its registered office located in Vadodara, Gujarat.
This development follows SPARC’s earlier board decision on February 10, 2025, where the company had approved the formation of a wholly owned subsidiary in India.
Genokine Biotech has been established with an authorised and subscribed capital of Rs 1,00,000. Subscription of shares in the WOS will be by way of cash consideration.
Genokine Biotech Limited will carry on the business of all types of research and development and other related services, including but not limited to support the development of products for human as well as non-human use, such as veterinary, agricultural, industrial products.
As a newly incorporated company, Genokine Biotech currently has no turnover.
The Certificate of Incorporation has been issued by the Ministry of Corporate Affairs, Government of India, on July 5, 2025.
Read also: Sun Pharma Gets SEC Nod to Begin Phase III Trial of Cough Drug Gefapixant
In December, SPARC signed a binding Letter of Intent (LOI) with the University of California, San Francisco (UCSF) through the office of OTMA, and Tiller Therapeutics Inc. to license SPARC’s rights in the joint intellectual property (IP) held between SPARC and UCSF for pre-clinical oncology asset along with associated IP.
SPARC is a clinical stage bio-pharmaceutical company. SPARC was formed in 2007 through a demerger from SUN PHARMA.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751